SPARQL
Query
Update
Search
Quick
Advanced
Co-occurrence
RelFinder
About
Sources
Admin
System Info
Repository Management
Search Configuration
Sources
15296473
Source:
http://linkedlifedata.com/resource/pubmed/id/15296473
Search
Subject
(
59
)
Predicate
Object
All
Download in:
JSON
RDF
N3/Turtle
N-Triples
Switch to
Custom View
Named Graph
All
UniProt
NCBIGene
DrugBank
ClinicalTrials
UMLS
PubMed
Mappings
MentionedEntities
Language
All
English
Español
Português
Français
Deutsch
Русский
日本語
Български
Inference
Explicit and implicit
Explicit only
Implicit only
Statements in which the resource exists as a subject.
Predicate
Object
rdf:type
pubmed:Citation
lifeskim:mentions
umls-concept:C0043210
,
umls-concept:C0076660
,
umls-concept:C0078058
,
umls-concept:C0175630
,
umls-concept:C0232970
,
umls-concept:C0244404
,
umls-concept:C0279025
,
umls-concept:C1171892
,
umls-concept:C1280500
pubmed:issue
2
pubmed:dateCreated
2004-8-6
pubmed:abstractText
To evaluate the effect of continuous combined hormone therapy (HT), tibolone and raloxifene on circulating vascular endothelial growth factor (VEGF) in postmenopausal women.
pubmed:language
eng
pubmed:journal
http://linkedlifedata.com/resource/pubmed/journal/9423848
pubmed:citationSubset
IM
pubmed:chemical
http://linkedlifedata.com/resource/pubmed/chemical/Estrogen Antagonists
,
http://linkedlifedata.com/resource/pubmed/chemical/Estrogens
,
http://linkedlifedata.com/resource/pubmed/chemical/Medroxyprogesterone
,
http://linkedlifedata.com/resource/pubmed/chemical/Norpregnenes
,
http://linkedlifedata.com/resource/pubmed/chemical/Raloxifene
,
http://linkedlifedata.com/resource/pubmed/chemical/Vascular Endothelial Growth Factor A
,
http://linkedlifedata.com/resource/pubmed/chemical/tibolone
pubmed:status
MEDLINE
pubmed:month
Aug
pubmed:issn
0804-4643
pubmed:author
pubmed-author:AlexandrouAA
,
pubmed-author:ChristodoulakosGG
,
pubmed-author:CreatsasGG
,
pubmed-author:LambrinoudakiII
,
pubmed-author:LiakakosTT
,
pubmed-author:PanoulisCC
,
pubmed-author:PapadiasCC
,
pubmed-author:SarandakouAA
pubmed:issnType
Print
pubmed:volume
151
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
187-92
pubmed:dateRevised
2004-11-17
pubmed:meshHeading
pubmed-meshheading:15296473-Estrogen Antagonists
,
pubmed-meshheading:15296473-Estrogen Replacement Therapy
,
pubmed-meshheading:15296473-Estrogens
,
pubmed-meshheading:15296473-Female
,
pubmed-meshheading:15296473-Greece
,
pubmed-meshheading:15296473-Humans
,
pubmed-meshheading:15296473-Medroxyprogesterone
,
pubmed-meshheading:15296473-Middle Aged
,
pubmed-meshheading:15296473-Norpregnenes
,
pubmed-meshheading:15296473-Postmenopause
,
pubmed-meshheading:15296473-Prospective Studies
,
pubmed-meshheading:15296473-Raloxifene
,
pubmed-meshheading:15296473-Vascular Endothelial Growth Factor A
pubmed:year
2004
pubmed:articleTitle
Effect of hormone therapy, tibolone and raloxifene on circulating vascular endothelial growth factor in Greek postmenopausal women.
pubmed:affiliation
2nd Department of Obstetrics and Gynecology, University of Athens, Aretaieion Hospital, Athens, Greece.
pubmed:publicationType
Journal Article
,
Clinical Trial
,
Controlled Clinical Trial